T
Power Law company profile
Twist Bioscience
Biotech & Life Sciences · South San Francisco, United States · Founded 2013 · IPO 2018 Unicorn
Valuation
$3.38B
Market cap · Apr/2026
Revenue
$377M
Latest reported FY
Global footprint
Where Twist Bioscience has talent and traffic
AI talent share
0.6%
of workforce is AI talent
(7 of 1,270 staff)
(7 of 1,270 staff)
Core AI10.08%
Other AI60.47%
Non-AI workforce1,26399.45%
Web traffic by country
190K
monthly visits
across markets
across markets
🇺🇸 United States33.2%
🇬🇧 United Kingdom6.1%
🏳️ Korea6.1%
🏳️ Republic of5.3%
🏳️ Peru5.2%
Patent intelligence
$84M patent portfolio · 108 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$84M
2.5% of market cap · 2.8× the top peer Krystal Biotech ($30M)
108 active patent families
Where Twist Bioscience innovates
PolynucleotideNucleic acid sequencingNucleic acid sequenceBiological organismMolecular biology
Above peer median on Legal
Quality vs same-sector peers
Twist Bioscience on the five Patsnap quality dimensions
Twist Bioscience in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Twist Bioscience concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Twist Bioscience and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Twist Bioscience on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.